Huntingtin inclusions do not down-regulate specific genes in the R6/2 Huntington's disease mouse

被引:21
作者
Sadri-Vakili, G.
Menon, A. S.
Farrell, L. A.
Keller-McGandy, C. E.
Cantuti-Castelvetri, I.
Standaert, D. G.
Augood, S. J.
Yohrling, G. J.
Cha, J-H. J.
机构
[1] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA
[2] Johnson & Johnson Pharmaceut, Res & Dev LLC, Spring House, PA 19477 USA
关键词
Huntington's disease; in situ hybridization; inclusions; laser capture microdissection; striatum; transcription;
D O I
10.1111/j.1460-9568.2006.04871.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Transcriptional dysregulation is a central pathogenic mechanism in Huntington's disease (HD); HID and transgenic mouse models of HID demonstrate down-regulation of specific genes at the level of mRNA expression. Furthermore, neuronal intranuclear inclusions (NIIs) have been identified in the brains of R6/2 mice and HID patients. One possibility is that NIIs contribute to transcriptional dysregulation by sequestering transcription factors. We therefore assessed the relationship between NIIs and transcriptional dysregulation in the R6/2 mouse, using double-label in situ hybridization combined with immunohistochemistry, and laser capture microdissection combined with quantitative real-time PCR. There was no difference in transcript levels of specific genes between NII-positive and Nil-negative neurons. These results demonstrate that NIIs do not cause decreases in D2, PPE and PSS mRNA levels in R6/2 striatum and therefore are not involved in the down-regulation of these specific genes in this HID model. In addition, these observations argue against the notion that NIIs protect against transcriptional dysregulation in HID.
引用
收藏
页码:3171 / 3175
页数:5
相关论文
共 31 条
  • [1] Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
    Arrasate, M
    Mitra, S
    Schweitzer, ES
    Segal, MR
    Finkbeiner, S
    [J]. NATURE, 2004, 431 (7010) : 805 - 810
  • [2] Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: A detailed cellular in situ hybridization study
    Augood, SJ
    Faull, RLM
    Love, DR
    Emson, PC
    [J]. NEUROSCIENCE, 1996, 72 (04) : 1023 - 1036
  • [3] BENN CL, 2004, TRIPLET REPEAT PROTO, P231
  • [4] Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene
    Cha, JHJ
    Kosinski, CM
    Kerner, JA
    Alsdorf, SA
    Mangiarini, L
    Davies, SW
    Penney, JB
    Bates, GP
    Young, AB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) : 6480 - 6485
  • [5] Transcriptional dysregulation in Huntington's disease
    Cha, JHJ
    [J]. TRENDS IN NEUROSCIENCES, 2000, 23 (09) : 387 - 392
  • [6] Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease
    Chen-Plotkin, AS
    Sadri-Vakill, G
    Yohrling, GJ
    Bravernan, MW
    Berin, CL
    Glajch, KE
    DiRocco, DP
    Farrella, LA
    Krainc, D
    Gines, S
    MacDonald, ME
    Cha, JHJ
    [J]. NEUROBIOLOGY OF DISEASE, 2006, 22 (02) : 233 - 241
  • [7] Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
    Davies, SW
    Turmaine, M
    Cozens, BA
    DiFiglia, M
    Sharp, AH
    Ross, CA
    Scherzinger, E
    Wanker, EE
    Mangiarini, L
    Bates, GP
    [J]. CELL, 1997, 90 (03) : 537 - 548
  • [8] Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?
    Davies, SW
    Beardsall, K
    Turmaine, M
    DiFiglia, M
    Aronin, N
    Bates, GP
    [J]. LANCET, 1998, 351 (9096) : 131 - 133
  • [9] Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
    DiFiglia, M
    Sapp, E
    Chase, KO
    Davies, SW
    Bates, GP
    Vonsattel, JP
    Aronin, N
    [J]. SCIENCE, 1997, 277 (5334) : 1990 - 1993
  • [10] Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease
    Dunah, AW
    Jeong, H
    Griffin, A
    Kim, YM
    Standaert, DG
    Hersch, SM
    Mouradian, MM
    Young, AB
    Tanese, N
    Krainc, D
    [J]. SCIENCE, 2002, 296 (5576) : 2238 - 2243